Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation: 06/11/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Travatan, travoprost, Date of authorisation: 27/11/2001, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Zyprexa Velotab, olanzapine, Date of authorisation: 03/02/2000, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva), sevelamer carbonate, Date of authorisation: 15/01/2015, Revision: 23, Status: Authorised

New fee regulation (from 1 January 2025)

Standard operating procedure for processing of requests for fee reduction falling under paragraph 5 of Article 6 of Regulation (EU) 2024/568

Human medicines European public assessment report (EPAR): Voncento, human coagulation factor VIII / human von willebrand factor, Date of authorisation: 12/08/2013, Revision: 16, Status: Authorised

Assessment templates and guidance (veterinary medicines)

Template - CVMP member comments on rapporteur’s reports

Data quality framework for medicines regulation